Exact Mass: 318.1368
Exact Mass Matches: 318.1368
Found 500 metabolites which its exact mass value is equals to given mass value 318.1368,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tebupirimfos
CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10232; ORIGINAL_PRECURSOR_SCAN_NO 10230 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10218; ORIGINAL_PRECURSOR_SCAN_NO 10216 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10254; ORIGINAL_PRECURSOR_SCAN_NO 10252 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10208; ORIGINAL_PRECURSOR_SCAN_NO 10207 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10252; ORIGINAL_PRECURSOR_SCAN_NO 10250 CONFIDENCE standard compound; INTERNAL_ID 1225; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10257; ORIGINAL_PRECURSOR_SCAN_NO 10256
Fluvoxamine
Fluvoxamine is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor. Though it is in the same class as other SSRI drugs, it is most often used to treat obsessive-compulsive disorder. Fluvoxamine has been in use in clinical practice since 1983 and has a clinical trial database comprised of approximately 35,000 patients. It was launched in the US in December 1994 and in Japan in June 1999. As of the end of 1995, more than 10 million patients worldwide have been treated with fluvoxamine. D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent CONFIDENCE standard compound; INTERNAL_ID 8519 D049990 - Membrane Transport Modulators Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(S,E)-Zearalenone
CONFIDENCE standard compound; INTERNAL_ID 211; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4903; ORIGINAL_PRECURSOR_SCAN_NO 4902 CONFIDENCE standard compound; INTERNAL_ID 211; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4907; ORIGINAL_PRECURSOR_SCAN_NO 4903 CONFIDENCE standard compound; INTERNAL_ID 211; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4915; ORIGINAL_PRECURSOR_SCAN_NO 4913 CONFIDENCE standard compound; INTERNAL_ID 211; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4892; ORIGINAL_PRECURSOR_SCAN_NO 4888 CONFIDENCE standard compound; INTERNAL_ID 211; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4889; ORIGINAL_PRECURSOR_SCAN_NO 4888 CONFIDENCE standard compound; INTERNAL_ID 211; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4992; ORIGINAL_PRECURSOR_SCAN_NO 4988 Fungal metabolite of Fusarium subspecies and of Gibberella zeae. Potential food mycotoxin. Has weak estrogenic activity and causes physiol. changes when ingested by animals as foodstuffs contaminant. (S,E)-Zearalenone is found in corn. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens Acquisition and generation of the data is financially supported in part by CREST/JST. D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2248 cis-Zearalenone is a metabolite of Fusarium species. Zearalenone is a mycotoxin produced mainly by fungi belonging to the genus Fusarium in foods and feeds. Possess oestrogenic activity in pigs, cattle and sheep, with low acute toxicity. Causes precocious development of mammae and other estrogenic effects in young gilts[1][2]. Zearalenone is a mycotoxin produced mainly by fungi belonging to the genus Fusarium in foods and feeds. Possess oestrogenic activity in pigs, cattle and sheep, with low acute toxicity. Causes precocious development of mammae and other estrogenic effects in young gilts[1][2].
Histidyltyrosine
Histidyltyrosine is a dipeptide composed of histidine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Asparaginyl-Tryptophan
Asparaginyl-Tryptophan is a dipeptide composed of asparagine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Tyrosyl-Histidine
Tyrosyl-Histidine is a dipeptide composed of tyrosine and histidine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Tryptophyl-Asparagine
Tryptophyl-Asparagine is a dipeptide composed of tryptophan and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
fluvoxamino acid
fluvoxamino acid is a metabolite of fluvoxamine. Fluvoxamine (brand name Luvox) is an antidepressant which functions as a selective serotonin reuptake inhibitor (SSRI). Fluvoxamine was first approved by the U.S. Food and Drug Administration (FDA) in 1993 for the treatment of obsessive compulsive disorder (OCD). Fluvoxamine CR (controlled release) is approved to treat social anxiety disorder. (Wikipedia)
2-Hydroxyenterodiol
2-Hydroxyenterodiol is a polyphenol metabolite detected in biological fluids (PMID: 20428313). A polyphenol metabolite detected in biological fluids [PhenolExplorer]
4-Hydroxyenterodiol
4-Hydroxyenterodiol is a polyphenol metabolite detected in biological fluids (PMID: 20428313). A polyphenol metabolite detected in biological fluids [PhenolExplorer]
6-Hydroxyenterodiol
6-Hydroxyenterodiol is a polyphenol metabolite detected in biological fluids (PMID: 20428313). A polyphenol metabolite detected in biological fluids [PhenolExplorer]
[(3-Hexyl-4-methyl-2-oxo-2H-chromen-7-yl)oxy]acetic acid
Imidazolone A
Nile red
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
(11S)-11-Methyl-15,17-bis(oxidanyl)-12-oxabicyclo[12.4.0]octadeca-1(18),2,14,16-tetraene-7,13-dione
Phenol
Erianin is a natural product found in Dendrobium thyrsiflorum and Dendrobium chrysotoxum with data available. Erianin, often used as an antipyretic and analgesic agent, could inhibit IDO-induced tumor angiogenesis. Erianin, often used as an antipyretic and analgesic agent, could inhibit IDO-induced tumor angiogenesis.
Laurycolactone A
Laurycolactone A is a natural product found in Eurycoma longifolia with data available.
3-(hydroxymethyl)-6-[4-(3-methylbut-2-enyloxy)benzyl]piperazine-2,5-dione
A piperazinone that is piperazine-2,5-dione substituted by a hydroxymethyl group at position 3 and a benzyl group at position 6 which in turn is substituted by a prenyloxy group at position 4. It has been isolated from Penicillium chrysogenum.
Imiprothrin
D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins CONFIDENCE standard compound; EAWAG_UCHEM_ID 2932
ethyl 2-{[(2S)-1-(2-phenylacetyl)pyrrolidin-2-yl]formamido}acetate
Tiemonium
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
2-O-??-D-Glucopyranoside-4-Hydroxy-4-(2-hdyroxyethyl)-2-cyclohexen-1-one
(1aS,3R,4R,4aR,6S,7R,8aS)-7-chloro-3,6-dihydroxy-3,4a,8,8-tetramethyl-octahydro-1aH-naphtho[1-b]oxirene-4-carboxylic acid
2-[6-acetyl-2,3-dihydro-5-hydroxybenzofuran-2-yl]prop-2-enyl 3-methylbutanoate
1-isobutyryyloxy-2-(E-3-methyloxiranyl)-4-angelyloxybenzene
3,5-dihydroxy-2-(1-oxoocta-2E,4E-dienyl)benzeneacetic acid ethyl ester|cytosporone F
Desacylcynaropicrin-(alpha-methacrylat)|Desacylcynaropicrin-
3-(8S*-hydroxynona-5-E-enyl)-6,8-dihydroxyisochromen-1-one|fusariumin
Griffithane A
A dimethoxybenzene that is 2,5-dimethoxyphenol substituted by a 3-(4-hydroxy-3-methoxyphenyl)propyl group at position 4. It has been isolated from the stems of Combretum griffithii and has been shown to exhibit anticancer activity.
Griffithane B
A dimethoxybenzene that is 2,6-dimethoxyphenol substituted by a 3-(4-hydroxy-3-methoxyphenyl)propyl group at position 3. It has been isolated from the stems of Combretum griffithii and has been shown to exhibit anticancer activity.
Griffithane C
A member of the class of catechols that is benzene-1,2-diol substituted by a methoxy group at position 5 and a 3-(3,4-dimethoxyphenyl)propyl group at position 4. It has been isolated from the stems of Combretum griffithii.
(R)-(+)-2-(3-hydroxy-3-phenylpropyl)-3,5,6-trimethoxyphenol|welwitschin C
(Z)-methyl 2-((1aS,1bR,5S,5aR,6aR)-5-acetoxy-1b-methyl-6-methylene-3-oxooctahydrocyclopropa [a]inden-4(1bH)-ylidene)propanoate|linderolide L
schomburgbiphenyl|[1,1-biphenyl]-2-(3-hydroxy-3-methylbutyl)-3-methoxy-4,4,5-triol
Erianin
Erianin is a natural product found in Dendrobium thyrsiflorum and Dendrobium chrysotoxum with data available. Erianin, often used as an antipyretic and analgesic agent, could inhibit IDO-induced tumor angiogenesis. Erianin, often used as an antipyretic and analgesic agent, could inhibit IDO-induced tumor angiogenesis.
1beta,14-dihydroxy-13-methoxy-8,11,13-podocarpatriene-2,7-dione|1??,14-Dihydroxy-13-methoxy-8,11,13-podocarpatriene-2,7-dione
(R)-3,4-dihydroxy-5,4,alpha-trimethoxybibenzyl|dendrocandin A
2-Methyl-2-(4-methyl-3-pentenyl)-5,7-dihydroxy-2H-1-benzopyran-6-carboxylic acid methyl ester
3-(1,1-Dimethylallyl)-6-dimethoxymethyl-7-methoxy-cumarin|6-dimethoxymethyl-3-(1,1-dimethyl-allyl)-7-methoxy-chromen-2-one
1-angelyloxy-2-(E-3-methyloxiranyl)-4-isobutyryloxybenzene
(1aR,4S,4aS,5S,9aS)-2,3,4,4a,5,9-hexahydro-4,4a,6-trimethyl-9-oxo-1aH-oxireno[8,8a]naphtho[2,3-b]furan-5-yl propanoate|1beta,10beta-epoxy-6beta-(propanoyloxy)furanoeremophilan-9-one
Zearalenone
A macrolide comprising a fourteen-membered lactone fused to 1,3-dihydroxybenzene; a potent estrogenic metabolite produced by some Giberella species. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE standard compound; INTERNAL_ID 5970 Origin: Microbe; Formula(Parent): C18H22O5; Bottle Name:zearalenone; PRIME Parent Name:Zearalenone; PRIME in-house No.:V0033 CONFIDENCE Reference Standard (Level 1) Zearalenone is a mycotoxin produced mainly by fungi belonging to the genus Fusarium in foods and feeds. Possess oestrogenic activity in pigs, cattle and sheep, with low acute toxicity. Causes precocious development of mammae and other estrogenic effects in young gilts[1][2]. Zearalenone is a mycotoxin produced mainly by fungi belonging to the genus Fusarium in foods and feeds. Possess oestrogenic activity in pigs, cattle and sheep, with low acute toxicity. Causes precocious development of mammae and other estrogenic effects in young gilts[1][2].
C18H22O5_1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (11E)
Fluvoxamine
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065689 - Cytochrome P-450 CYP2C19 Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AB - Selective serotonin reuptake inhibitors D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C94725 - Selective Serotonin Reuptake Inhibitor D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2740
1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10-octahydro-14,16-dihydroxy-3-methyl-7-oxo-, (E)-
Ala Ala Ala Ser
Ala Ala Gly Thr
Ala Ala Ser Ala
Ala Ala Thr Gly
Ala Asp Gly Gly
Ala Gly Ala Thr
Ala Gly Asp Gly
Ala Gly Thr Ala
Ala Ser Ala Ala
Ala Thr Ala Gly
Ala Thr Gly Ala
Asp Ala Gly Gly
Asp Gly Ala Gly
Asp Gly Gly Ala
Glu Gly Gly Gly
Gly Ala Ala Thr
Gly Ala Asp Gly
Gly Ala Thr Ala
Gly Asp Ala Gly
Gly Asp Gly Ala
Gly Glu Gly Gly
Gly Gly Asp Ala
Gly Gly Ser Val
Gly Gly Val Ser
Gly Ser Gly Val
Gly Ser Val Gly
Gly Thr Ala Ala
Gly Val Gly Ser
Gly Val Ser Gly
Ser Ala Ala Ala
Ser Gly Gly Val
Ser Gly Val Gly
Ser Val Gly Gly
Thr Ala Ala Gly
Thr Ala Gly Ala
Thr Gly Ala Ala
Val Gly Gly Ser
Val Gly Ser Gly
Val Ser Gly Gly
His-tyr
A dipeptide formed from L-histidine and L-tyrosine residues.
Tyr-his
A dipeptide formed from L-tyrosine and L-histidine residues.
2-Hydroxyenterodiol
4-Hydroxyenterodiol
6-Hydroxyenterodiol
2-benzyl-1,2,3,4-tetrahydro-benzo[b][1,6]naphthyridine-10-carboxylic acid
6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinol
1-Boc-1,2-dihydro-2-oxo-spiro[4H-3,1-benzoxazine-4,4-piperidine]
1-[2-(2,3-dihydroindol-1-yl)-2-oxoethyl]-2-methylindole-3-carbaldehyde
N-Carbamimidoyl-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide
1-(1-phenylmethoxycarbonylpiperidin-4-yl)azetidine-3-carboxylic acid
Noopept
Omberacetam (GVS-111) is a medication promoted and prescribed in Russia and neighbouring countries as a nootropic.
4-(TRANS-4-ETHYLCYCLOHEXYL)-3,4,5-TRIFLUORO-1,1-BIPHENYL
methyl 1-(2,2-dimethoxyethyl)-6-oxo-2-phenylpyrimidine-5-carboxylate
3-Pyridazinecarboxylic acid, 6-(4-fluoro-2-methylphenyl)-, 2-(methoxyacetyl)hydrazide
(S)-5-AMINO-2-(BENZYLOXYCARBONYLAMINO)PENTANOIC ACID
N-[5-(TRIMETHOXYSILYL)-2-AZA-1-OXOPENTYL]CAPROLACTAM
(9H-FLUOREN-9-YL)METHYL 2,3-DIAMINOPROPANOATE HYDROCHLORIDE
(4-Aminophenyl)(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)methanone hydrochloride
6-(4-methoxyphenyl)-5-pyridin-3-ylfuro[2,3-d]pyrimidin-4-amine
Ethyl 4-hydroxy-1-isopentyl-7-methyl-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxylate
(3R)-1-benzyl-3-methyl-4-[(2-methylpropan-2-yl)oxy]-6-(oxomethylidene)piperazine-2,5-dione
1-[6-(2,5-dioxopyrrol-1-yl)-3,5,5-trimethylhexyl]pyrrole-2,5-dione
4-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)butanoic acid
tert-Butyl 4-(2-oxobenzo[d]oxazol-3(2H)-yl)piperidine-1-carboxylate
N-(3-methoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine
3-(3,5-DIMETHOXYPHENYL)-1-(2-NAPHTHYL)PROP-2-EN-1-ONE
METHYL 6-N-BOC-AMINO-3-FORMYL-1H-INDOLE-4-CARBOXYLATE
Benzene,1,1-[oxybis(methylene)]bis[3,4-dimethoxy- (9CI)
Benzoic acid,4-(phenylmethoxy)-, phenylmethyl ester
N,N-Di-t-butyl-2,3-diaMidobutanetin(II), 98\\%, 50-1150, contained in 50 Ml Swagelok cylinder (96-1070) for CVD/ALD
(2S,5R)-6-(benzyloxy)-N-formyl-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carbohydrazide
2-Naphthalenecarboxylic acid, 4,6,7-triMethoxy-8-(1-Methylethyl)-, Methyl ester
ETHYL 4-HYDROXY-8-ISOPROPYL-6,7-DIMETHOXY-2-NAPHTHOATE
(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid
LT175, a dual PPARα/γ ligand, is an orally active partial agonist against PPARγ(hPPARα:EC50=0.22 μm; mPPARα:EC50=0.26 μm; hPPARγ:EC50=0.48 μm). LT175 interacts with PPARγ and affects the recruitment of the coregulators cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1). LT175 interacts with PPARγ in a hydrophobic region called “diphenyl pocket”. LT175 has potent insulin-sensitizing effects and reduced adipogenic properties[1].
Quinelorane hydrochloride
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist
2,5-Piperazinedione, 3-(hydroxymethyl)-6-((4-((3-methyl-2-butenyl)oxy)phenyl)methyl)-, (3S,6S)-
7-Hydroxy-8-[[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-4-methyl-1-benzopyran-2-one
3-(6-Benzyloxy-naphthalen-2-yl)-acrylic acid methyl ester
[4-(4-Phenylphenyl)-1-triazolyl]-(1-pyrrolidinyl)methanone
2-(4-Hydroxy-5-phenyl-1H-pyrazol-3-YL)-1H-benzoimidazole-5-carboxamidine
6-[N-(4-(Aminomethyl)phenyl)carbamyl]-2-naphthalenecarboxamidine
N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide
2-Acetamido-3-[(4-hydroxy-1-oxononan-3-yl)sulfanyl]propanoate
2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-oxo-2-sulfanylidenepyrimidin-5-yl]ethyl-methylazanium
Nile blue
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
N-methyl-N-[4-[(2-oxo-1-naphthalenylidene)methylamino]phenyl]acetamide
5-[(3,4-Dimethoxyphenyl)methyl]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione
3-amino-N-tert-butyl-6-methyl-7,8-dihydro-5H-thieno[2,3-b][1,6]naphthyridine-2-carboxamide
[5-(2,5-Dimethoxyphenyl)-3-isoxazolyl]-(4-morpholinyl)methanone
Ethyl 4-[4-methyl-6-(trifluoromethyl)pyrimidin-2-yl]piperazine-1-carboxylate
2-(4-Methoxyphenyl)-3-propylimidazo[4,5-b]quinoxaline
2-[2-(Difluoromethoxy)anilino]-1-(2,3-dihydroindol-1-yl)ethanone
3-(1-Azepanyl)-4-chloro-1-(2-methylphenyl)pyrrole-2,5-dione
[4-(3-Chlorophenyl)-1-piperazinyl]-(2,5-dimethyl-3-furanyl)methanone
4-methyl-N-[(1-naphthylacetyl)oxy]benzenecarboximidamide
5-amino-4-(1H-benzimidazol-2-yl)-2,2-dimethyl-1-phenyl-3-pyrrolone
2-(2,3-dihydro-1,4-benzoxazin-4-yl)-N-(phenylmethyl)-4-pyrimidinamine
4-(2-amino-6,7-dihydro-5H-pyrimido[5,4-c]carbazol-10-yl)-2-methylbut-3-yn-2-ol
N-(6-acetyl-1,3-benzodioxol-5-yl)-2-(2-methyl-1-piperidinyl)acetamide
2-[1-Hydroxy-3-(4-methoxyphenyl)propyl]-3,5-dimethoxyphenol
(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-azetidinecarbonitrile
(2R,3R,4R)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]azetidine-2-carbonitrile
(2S,3S,4S)-4-(hydroxymethyl)-3-[4-[2-(3-methoxyphenyl)ethynyl]phenyl]-2-azetidinecarbonitrile
(3Z)-2-(4-methoxybenzyl)-3-(4-methoxybenzylidene)butanedinitrile
N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+)
(2Z,4Z)-2-hydroxy-4-[(3aS,5aS,9aS,9bS)-3a-methyl-3,7-dioxododecahydro-6H-cyclopenta[a]naphthalen-6-ylidene]but-2-enoic acid
3-(4-Hydroxyphenyl)-9-methyl-5,9-diaza-14-azoniatetracyclo[6.6.1.02,6.011,15]pentadeca-1(14),2(6),3,8(15),10-pentaen-7-one
Triethyl 2-carboxymethyl-1,2,3-propane-tricarboxylate
(S,E)-Zearalenone
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
NK372135A
A dinitrile that is butanedinitrile substituted by 4-methoxybenzyl and 4-methoxybenzylidene groups at positions 2 and 3 respectively. Isolated from the culture broth of the fungus Neosartorya fischeri, it exhibits antifungal activity.
(2Z,10Z)-3-hydroxy-5,17-dioxo-4,5-secoestra-2,10-diene-3-oic acid
An oxo seco-steroid that is a meta-cleavage metabolite in the estrogen degradation pathway; an unstable precursor to pyridinestrone acid.
SLMP53-1
SLMP53-1 is a wild-type and mutant p53 reactivator with promising antitumor activity. SLMP53-1 mediates the reprograming of glucose metabolism in cancer cells. SLMP53-1 depletes angiogenesis, decreasing endothelial cell tube formation and vascular endothelial growth factor (VEGF) expression levels[1][2].
(2e,4e)-n-{3-hydroxy-3-[2-(c-hydroxycarbonimidoyl)ethyl]-6-oxocyclohexa-1,4-dien-1-yl}-6-methylhepta-2,4-dienimidic acid
ethyl 2-[7-hydroxy-4-oxo-2-(pent-1-en-1-yl)-2,3-dihydro-1-benzopyran-5-yl]acetate
(2e)-n-(4-{[(2e)-1-hydroxy-3-(methylsulfanyl)prop-2-en-1-ylidene]amino}butyl)-3-phenylprop-2-enimidic acid
(6ar,9s,9ar,9bs)-3,6a-dimethyl-9-[(2s)-2-methylbutanoyl]-1h,9h,9ah,9bh-furo[2,3-h]isochromene-6,8-dione
(3r,5e)-14,16-dihydroxy-3-methyl-4,7,8,9,10,12-hexahydro-3h-2-benzoxacyclotetradecine-1,11-dione
[(1r,4s)-1,4-dihydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-yl]methanesulfonic acid
(2s)-2-(6-acetyl-5-hydroxy-1-benzofuran-2-yl)propyl 3-methylbutanoate
14,16-dihydroxy-3-methyl-4,5,6,7,8,12-hexahydro-3h-2-benzoxacyclotetradecine-1,11-dione
(1s,2r,5r,9s,10s,11r,12r,15r)-11-hydroxy-2,6,9,15-tetramethyl-13-oxatetracyclo[10.2.1.0²,¹⁰.0⁵,⁹]pentadec-6-ene-3,8,14-trione
7,10-dihydroxy-1-(hydroxymethyl)-6-methoxy-1,4a-dimethyl-3,4-dihydro-2h-phenanthren-9-one
(1s,2r,7r,8s,9s,17s)-8-hydroxy-1,17-dimethyl-12-methylidene-10,13-dioxatetracyclo[7.7.1.0²,⁷.0¹¹,¹⁵]heptadec-11(15)-ene-14,16-dione
3,5-dihydroxy-1-methyl-3-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-6h-pyrazin-2-one
(2r,3r)-3-hydroxy-2-(hydroxymethyl)-4-methoxy-4-oxobutyl (2e,4s,5s,6e)-4,5-dihydroxyocta-2,6-dienoate
(1s,2r,9s,11r,12r,15r)-11-hydroxy-2,6,9,15-tetramethyl-13-oxatetracyclo[10.2.1.0²,¹⁰.0⁵,⁹]pentadec-6-ene-3,8,14-trione
5-[3-(4-hydroxy-3-methoxyphenyl)propyl]-2,4-dimethoxyphenol
4a-hydroxy-3,5,8-trimethylidene-2-oxo-hexahydro-3ah-azuleno[6,5-b]furan-6-yl propanoate
n-(4-{[1-hydroxy-3-(methylsulfanyl)prop-2-en-1-ylidene]amino}butyl)-3-phenylprop-2-enimidic acid
(6r)-6-[(2s)-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propyl]-5,6-dihydropyran-2-one
[(1r,3as,4s,8ar)-1,4-dihydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-yl]methanesulfonic acid
6,8-dihydroxy-3-[(8s)-8-hydroxynon-5-en-1-yl]isochromen-1-one
1-(2,3-dimethoxy-5-methylphenoxy)-2,3-dimethoxy-5-methylbenzene
(4s,4as,10as)-4,8-dihydroxy-7-methoxy-1,1,4a-trimethyl-2,4,10,10a-tetrahydrophenanthrene-3,9-dione
6,9,10-trimethyl-2-oxo-4,14-dioxatetracyclo[7.5.0.0¹,¹³.0³,⁷]tetradeca-3(7),5-dien-8-yl propanoate
3-methoxy-5-[(1r)-1-methoxy-2-(4-methoxy-3-methylphenyl)ethyl]benzene-1,2-diol
(2s,3s)-1-(3-hydroxy-4-methoxyphenyl)-2-(4-methoxyphenyl)butane-1,3-diol
1β,14-dihydroxy-13-methoxy-8,11,13-podocar-patriene-2,7-dione
{"Ingredient_id": "HBIN002340","Ingredient_name": "1\u03b2,14-dihydroxy-13-methoxy-8,11,13-podocar-patriene-2,7-dione","Alias": "NA","Ingredient_formula": "C18H22O5","Ingredient_Smile": "CC1(CC(=O)C(C2(C1CC(=O)C3=C2C=CC(=C3O)OC)C)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5998","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
